Isfahan University of Medical Sciences
Items where Author is "Somi, M. H."
Up a level |
Article
(2021) Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. International Journal of Cancer. pp. 594-605. ISSN 00207136 (ISSN)
(2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. pp. 473-481. ISSN 1473-3099 (Print) 1473-3099
(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838
(2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology. pp. 1590-1594. ISSN 0815-9319
(2019) Iranian Registry of Crohn's and Colitis (IRCC): first nation-wide IBD registry in Middle East, a study protocol. Journal of Crohns & Colitis. S492-S493. ISSN 1873-9946
(2019) Iranian Registry of Crohn's and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East. Intest Res. ISSN 1598-9100 (Print) 1598-9100 (Linking)
(2019) The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets. Journal of Hepatology. E233-E233. ISSN 0168-8278
(2018) Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran. Archives of Virology. pp. 1479-1488. ISSN 0304-8608
(2018) Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. AMERICAN JOURNAL OF EPIDEMIOLOGY. pp. 647-655. ISSN 00029262 (ISSN)
(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504
(2017) Effect of PUFAs Oral Administration on the Amount of Apoptotic Caspases Enzymes in Gastric Cancer Patients Undergoing Chemotherapy. Anti-Cancer Agents in Medicinal Chemistry. pp. 93-101. ISSN 1871-5206
(2016) Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran. Archives of Iranian Medicine. pp. 2-15. ISSN 1029-2977
(2016) The effect of omega-fatty acids on the expression of phospholipase A(2) group 2A in human gastric cancer patients. Journal of Research in Medical Sciences. ISSN 1735-1995
(2016) The effect of ω-fatty acids on the expression of phospholipase A2 group 2A in human gastric cancer patients. Journal of Research in Medical Sciences. ISSN 17351995 (ISSN)
(2015) Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces. Iranian journal of microbiology. pp. 214-20. ISSN 2008-3289 (Print) 2008-3289 (Linking)